Common side-effects of hepatitis C protease inhibitors: clinical management advice published
Earlier deaths in people with HIV due to drugs, alcohol, co-infections, poorly controlled HIV - not rapid ageing
Persistence of very low levels of virus increase risk of relapse after hepatitis C therapy
Hepatitis C drug boceprevir achieves 70% viral suppression rate in HIV co-infected people within 24 weeks
New European HIV treatment guidelines expand treatment recommendations but anticipate possible drug shortages
People on methadone can succeed on hepatitis C treatment
Gene variant that helps hepatitis C treatment may hinder HIV treatment
Coffee consumption reduces side-effects in people on hepatitis C treatment
Boceprevir response and resistance differs according to HCV genotype 1 subtype
